MedTrace Logo

Surgical Treatment of Ischemic Mitral Regurgitation

NCT01368575 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 420

Last updated 2015-09-23

No results posted yet for this study

Summary

The primary objective is to estimate surgical treatment (prosthesis or plastic) of moderate and severe ischemic mitral regurgitation combined with CABG in patients with CAD and impact on heart failure and progress of mitral regurgitation.

Conditions

  • Mitral Valve Insufficiency

Interventions

PROCEDURE

CABG

CABG

PROCEDURE

CABG combined with MV repair with remodeling annuloplasty rigid ring

CABG combined with MV repair with remodeling annuloplasty rigid ring

PROCEDURE

CABG combined with MV repair with remodeling annuloplasty rigid ring

CABG combined with MV repair with remodeling annuloplasty rigid ring

PROCEDURE

CABG combined with MV repair with remodeling annuloplasty rigid ring and endoventricularplasty of subvalvular apparatus

CABG combined with MV repair with remodeling annuloplasty

PROCEDURE

CABG and MV replacement

coronary artery bypass grafting and mitral valve replacement

Sponsors & Collaborators

  • Meshalkin Research Institute of Pathology of Circulation

    lead NETWORK

Principal Investigators

  • Alexander Cherniavskiy, MD, PhD · State Research Institute of Circulation Patholody Novosibirsk, 630055 Russian Federation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2014-05-31
Completion
2015-11-30

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01368575 on ClinicalTrials.gov